Key Brain Signaling Mechanism For Rapidly Acting Antidepressants, Yale University Study
11/20/2013 6:28:14 AM
Two years ago, mammalian target of rapamycin or mTOR, a signaling protein, was identified as a key mediator of the antidepressant effects of ketamine, the first rapidly acting antidepressant medication to be identified. Several years later, a group at the National Institutes of Mental Health Intramural Program reported that scopolamine, a muscarinic acetylcholine receptor antagonist, also produced rapidly appearing antidepressant effects, similar to the actions of ketamine.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by